Ignyta Receives $10 Million Through Expanded Capital Term Loan From Silicon Valley Bank

Published: Jan 06, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (OTCQB:RXDX), an oncology precision medicine biotechnology company, announced today that Silicon Valley Bank (SVB) has bolstered its support of Ignyta through an expanded $10M capital term loan facility. The new facility replaces the previous $1.5M facility entered into between a wholly-owned subsidiary of Ignyta and SVB in June 2012 and February 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news